Rhenman & Partners Asset Management Ab Sanofi Transaction History

Rhenman & Partners Asset Management Ab

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Jan 19, 2018	SELL	$42.86 - $50.61 $5.57 Million - $6.58 Million	-130,000 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$47.04 - $50.34 $6.12 Million - $6.54 Million	130,000	130,000 $6.47 Million

800

266M

1.82M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $137B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.